Lauriane leads the Applied Organoid Technologies group. Her research focuses on turning organoid-based models and IHB technologies into assays ready to use for drug development by focusing on clinically known evidence and preexisting preclinical assays. She has a strong interest in translational research and seeks for scientific challenges in the field of disease modelling, immunology and oncology.
